Insiders · FATE

John Mendlein

Director at Fate Therapeutics Inc (FATE)

John Mendlein has filed 13 insider reports with the SEC since June 2021, as director at Fate Therapeutics Inc (FATE) and director at Omega Therapeutics, Inc. (OMGA). John Mendlein made no open-market purchases or sales in the last 12 months. The latest filing, on December 29, 2025, is a Form 144 notice: John Mendlein plans to sell 38,428 FATE shares (~$38.9K).

Filings
13
Companies
2
Bought on market
$698K
Sold on market
$1.14M

Companies where John Mendlein is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
Fate Therapeutics Inc logo
FATE
Fate Therapeutics Inc
Director311,231$698K$1.14M$5.60$0.919-84%Dec 29, 2025
Omega Therapeutics, Inc. logo
OMGA
Omega Therapeutics, Inc.
DirectorJun 21, 2024

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record. Price now: the latest daily close, against the average buy price.

Every filing

Compare John Mendlein with

Other insiders at the same companies

Questions about John Mendlein

What is John Mendlein's role at Fate Therapeutics Inc?
John Mendlein reports to the SEC as director at Fate Therapeutics Inc (FATE), according to the latest filing on December 29, 2025. John Mendlein has also filed as director at Omega Therapeutics, Inc. (OMGA).
How many shares does John Mendlein own?
After the latest filing that states it, John Mendlein directly owned 311,231 shares of Fate Therapeutics Inc (FATE). Shares held through trusts, funds or family members are reported separately and are not counted here.
Has John Mendlein bought or sold stock recently?
The most recent open-market purchase was on January 13, 2023: bought 124,679 shares of Fate Therapeutics Inc (FATE) for $698K at an average of $5.60. The most recent open-market sale was on June 3, 2022: sold 1,364 shares of Fate Therapeutics Inc (FATE) for $31.1K at an average of $22.79.
How do I get alerts when John Mendlein files?
Follow John Mendlein on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.

From SEC Forms 3, 4, 5 and 144 filed by John Mendlein (SEC CIK 0001238362). Totals count each trade once, skipping amendments whose original is on file, from Jun 4, 2021 on. View on SEC EDGAR · Get this as JSON